The United States may be in for a significant wave of evictions in a year or so, the unintended consequence of work to trim Medicaid rolls expanded during the COVID-19 public health emergency, according to new research from ...
Feb 19, 2024
0
0
The abortion pill will become available in Japan for the first time after the health ministry approved the drug used to terminate early-stage pregnancy.
Apr 29, 2023
0
2
Almost half of Australian adults are harmed by alcoholic products consumed by another person, a new study indicates, as researchers probe alcohol's widespread negative effects.
Apr 13, 2023
0
3
The remobilization of finger joints that have been damaged by illness or injury is an emerging market in the field of demand-driven patient care. The FingerKIt consortium, which brings together five Fraunhofer institutes, ...
Dec 1, 2022
0
30
Challenges with data collection and infrastructure are affecting medical workforce research and access to medical care, particularly in rural and regional Australia, according to the authors of a Perspective published by ...
Mar 8, 2021
0
0
Governments around the world ramped up the battle against the new coronavirus on Saturday by shutting borders and promising cash injections, as Spain emerged as a global hotspot registering more than 1,500 new infections ...
Mar 14, 2020
0
3
Rather than functioning as substitutes for hospital-based emergency departments, freestanding emergency departments have increased local market spending on emergency care in three of four states' markets where they have entered, ...
Oct 23, 2019
0
6
Growth in global prescription drug spending will slow to the lowest rate in decades as low-cost generic drugs continue replacing former blockbusters in the U.S. and Europe, where governments face new pressure to reduce health ...
Nov 19, 2013
0
0
Budweiser, Steel Reserve, Colt 45, Bud Ice and Bud Light – were consumed in the highest quantities by emergency room patients, according to a new pilot study from researchers at The Center on Alcohol Marketing and Youth ...
Aug 14, 2013
0
0
Canadian drugmaker Valeant Pharmaceuticals said Monday that it will pay $8.7 billion to buy Bausch + Lomb, one of the world's best-known makers of contact lenses, in a massive expansion of Valeant's smaller ophthalmology ...
May 27, 2013
0
0
